EP3773573
ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
12.4.2019EP published:
18.3.2026EP application number:
19785592.7
EPO information:
European Patent Register
Max expiry date:
11.4.2039Expiry date:
17.7.2026
Title in English:
ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)Language of the patent:
English
Timeline
Today
12.4.2019EP application
18.3.2026EP Publication
17.7.2026Expires
Owner
Name:
Morphic Therapeutic, Inc.Address:
35 Gatehouse Drive A2, Waltham, MA 02451, US
Inventor
Name:
BURSAVICH, Matthew G.Address:
Needham, MA 02494, US
Name:
TROAST, Dawn M.Address:
Bedford, MA 01730, US
Name:
HARRISON, Bryce A.Address:
Framingham, MA 01701, US
Name:
LIPPA, Blaise S.Address:
Newton, Massachusetts 02459, US
Name:
ROGERS, Bruce N.Address:
Belmont, MA 02478, US
Name:
KONZE, Kyle D.Address:
New York 11215, US
Name:
GERASYUTO, Aleksey I.Address:
Flemington, NJ 08822, US
Name:
DAY, TylerAddress:
New York, NY 10036, US
Name:
LIN, Fu-yangAddress:
Sudbury, MA 01776, US
Name:
HAHN, Kristopher N.Address:
Medford, MA 02155, US
Name:
SVENSSON, Mats A.Address:
New Yor, NY 10011, US
Name:
KIM, ByungchanAddress:
West New York, NJ 07093, US
Name:
ZHONG, ChengAddress:
Belmont, MA 02478, US
Name:
LUGOVSKOY, Alexey A.Address:
Belmont, MA 02478, US
Name:
SOSA, BrianAddress:
Cambridge, MA 02139, US
Priority
Number:
201862656742 PDate:
12.4.2018Country:
US
Classification
Categories:
A61K 31/4375, C07D 207/04, C07D 471/04, C07D 205/08, C07D 213/64, C07D 239/90, C07D 241/18, C07D 401/12, C07D 401/14, C07D 413/12, C07D 413/14, C07D 487/04, C07D 237/32, C07D 401/06